ConnectedNest for Cancer
What You Need to Know Before You Apply
What is the purpose of this trial?
Social determinants of health (SDoH) such as housing instability, food insecurity, and financial burden largely shape the health and well-being of individuals, create health inequities, and drive a large portion of avoidable adverse health outcomes and healthcare costs. With new advancements in treatment and rising out-of-pocket expenses, individuals facing cancer are especially vulnerable to the adverse effects of SDoH. To address these barriers, a novel solution is needed to support oncology patients, clinical teams, and community-based organizations (CBOs) across the cancer continuum. In a Phase I contract award, XanthosHealth developed ConnectedNest, a novel electronic social care referral platform to screen for SDoH needs and connect individuals with cancer to social and community services provided by CBOs while engaging the oncology team in the SDoH referral process. Through additional funding, a pilot study was completed in Minneapolis, Minnesota, in partnership with Minnesota Cancer Alliance, involving the collaboration of 14 CBOs focused on cancer. 50 cancer survivors from these CBOs were enrolled to utilize the ConnectedNest platform for a 90-day duration. Our study involved the collection and analysis of crucial metrics related to patient and CBO engagement, SDoH needs, and the volume of feasible social care referrals. In Phase II, the technical features and integration capabilities of ConnectedNest will be enhanced based on learnings in Phase I and completed pilot study. The platform will be implemented and tested among patients seen at multiple oncology clinics, evaluating health outcomes of patients who use the platform.
Who Is on the Research Team?
Helen Parsons, PhD
Principal Investigator
University of Minnesota
Are You a Good Fit for This Trial?
This trial is for adults over 18 who can read and write in English, are being seen at a participating Minnesota oncology clinic, and are either undergoing active cancer therapy or are in survivorship. It aims to help them with social and health challenges related to their condition.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Pilot Study
50 cancer survivors utilized the ConnectedNest platform for a 90-day duration to assess patient and CBO engagement, SDoH needs, and social care referrals.
Phase II Implementation
The platform is implemented and tested among patients at multiple oncology clinics to evaluate health outcomes.
Follow-up
Participants are monitored for changes in social needs, quality of life, and satisfaction with care after using the platform.
What Are the Treatments Tested in This Trial?
Interventions
- ConnectedNest
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Minnesota
Lead Sponsor